ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,320.76
0.43%
Dow Jones
42,456.53
0.67%
Gold vs US Dollar
2,649.43
-0.86%
Brent Oil
71.865
1.29%
Bitcoin
66,135.99
1.47%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ESSA Pharma Inc (EPIX)

  7. ESSA Pharma Inc (EPIX) News

ESSA Pharma (EPIX)

ESSA Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EPIX
DateTimeSourceHeadlineSymbolCompany
13/09/202422:19PR Newswire (US)ESSA Pharma Presents Updated Phase 1/2 Masofaniten (EPI-7386) Clinical Data at the 2024 ESMO CongressNASDAQ:EPIXESSA Pharma Inc
13/09/202422:19PR Newswire (Canada)ESSA Pharma Presents Updated Phase 1/2 Masofaniten (EPI-7386) Clinical Data at the 2024 ESMO CongressNASDAQ:EPIXESSA Pharma Inc
11/09/202421:05PR Newswire (US)ESSA Pharma to Present at the 2024 Cantor Global Healthcare ConferenceNASDAQ:EPIXESSA Pharma Inc
11/09/202421:05PR Newswire (Canada)ESSA Pharma to Present at the 2024 Cantor Global Healthcare ConferenceNASDAQ:EPIXESSA Pharma Inc
09/09/202419:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EPIXESSA Pharma Inc
03/09/202423:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EPIXESSA Pharma Inc
03/09/202421:17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EPIXESSA Pharma Inc
05/08/202412:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EPIXESSA Pharma Inc
05/08/202412:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EPIXESSA Pharma Inc
05/08/202412:00PR Newswire (US)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2024NASDAQ:EPIXESSA Pharma Inc
05/08/202412:00PR Newswire (Canada)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2024NASDAQ:EPIXESSA Pharma Inc
08/07/202421:05PR Newswire (US)ESSA Pharma to Present at the JonesHealthcare Seaside SummitNASDAQ:EPIXESSA Pharma Inc
08/07/202421:05PR Newswire (Canada)ESSA Pharma to Present at the JonesHealthcare Seaside SummitNASDAQ:EPIXESSA Pharma Inc
30/05/202413:00PR Newswire (Canada)ESSA Pharma to Present at the Jefferies Global Healthcare ConferenceNASDAQ:EPIXESSA Pharma Inc
30/05/202413:00PR Newswire (US)ESSA Pharma to Present at the Jefferies Global Healthcare ConferenceNASDAQ:EPIXESSA Pharma Inc
14/05/202412:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EPIXESSA Pharma Inc
14/05/202412:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EPIXESSA Pharma Inc
14/05/202412:00PR Newswire (Canada)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024NASDAQ:EPIXESSA Pharma Inc
14/05/202412:00PR Newswire (US)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024NASDAQ:EPIXESSA Pharma Inc
06/05/202422:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EPIXESSA Pharma Inc
09/04/202413:00PR Newswire (US)ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceNASDAQ:EPIXESSA Pharma Inc
09/04/202413:00PR Newswire (Canada)ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceNASDAQ:EPIXESSA Pharma Inc
08/03/202401:13PR Newswire (Canada)ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERSNASDAQ:EPIXESSA Pharma Inc
08/03/202401:13PR Newswire (US)ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERSNASDAQ:EPIXESSA Pharma Inc
07/03/202422:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EPIXESSA Pharma Inc
05/03/202423:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EPIXESSA Pharma Inc
13/02/202412:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EPIXESSA Pharma Inc
13/02/202412:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EPIXESSA Pharma Inc
13/02/202412:00PR Newswire (US)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023NASDAQ:EPIXESSA Pharma Inc
13/02/202412:00PR Newswire (Canada)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023NASDAQ:EPIXESSA Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:EPIX

Your Recent History

NASDAQ
LYL
Dragon Victory
TG
GE91
Genmab
EU
XS2244941733
Tulip Mortgage Funding 2...
GATE
SCNSOLETH
Socean Staked Sol
ASX
WOA
Wide Open Agriculture
KUCN
TMTBTC
Traxia Membership Token
LSE
80RF
North.water.fin
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved